These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12236668)

  • 1. A search for guidance: examining prenatal substance exposure protocols.
    Zellman GL; Fair C; Houbé J; Wong M
    Matern Child Health J; 2002 Sep; 6(3):205-12. PubMed ID: 12236668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal illicit drug screening practices in Iowa: the impact of utilization of a structured screening protocol.
    Oral R; Strang T
    J Perinatol; 2006 Nov; 26(11):660-6. PubMed ID: 17036035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn drug testing practices in Iowa birthing hospitals.
    Wood KE; Smith P; Krasowski MD
    J Neonatal Perinatal Med; 2017; 10(4):445-450. PubMed ID: 29286931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Screening in Neonates.
    Bell SG
    Neonatal Netw; 2016; 35(5):321-6. PubMed ID: 27636697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of legal and hospital policies on physician response to prenatal substance exposure.
    Mendez D; Jacobson PD; Hassmiller KM; Zellman GL
    Matern Child Health J; 2003 Sep; 7(3):187-96. PubMed ID: 14509414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide practices for screening and reporting prenatal cocaine abuse: a survey of teaching programs.
    Pelham TL; DeJong AR
    Child Abuse Negl; 1992; 16(5):763-70. PubMed ID: 1393735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use.
    Jarlenski M; Hogan C; Bogen DL; Chang JC; Bodnar LM; Van Nostrand E
    Womens Health Issues; 2017; 27(3):264-270. PubMed ID: 28129942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive toxicology screening in newborns: ethical issues in the decision to legally intervene.
    Burns DL
    Pediatr Nurs; 1997; 23(1):73-5; discussion 76-8, 86. PubMed ID: 9137025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying infants at risk for neonatal abstinence syndrome: a retrospective cohort comparison study of 3 screening approaches.
    Murphy-Oikonen J; Montelpare WJ; Southon S; Bertoldo L; Persichino N
    J Perinat Neonatal Nurs; 2010; 24(4):366-72. PubMed ID: 21045617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical Considerations for Perinatal Toxicology Screening.
    Kohsman MG
    Neonatal Netw; 2016; 35(5):268-76. PubMed ID: 27636690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the pregnant woman who is using drugs: implications for perinatal and neonatal care.
    Casper T; Arbour MW
    J Midwifery Womens Health; 2013; 58(6):697-701. PubMed ID: 24015821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant Women with Substance Use Disorders - The Harm Associated with Punitive Approaches.
    Haffajee RL; Faherty LJ; Zivin K
    N Engl J Med; 2021 Jun; 384(25):2364-2367. PubMed ID: 34161722
    [No Abstract]   [Full Text] [Related]  

  • 14. The problem of the drug-exposed newborn: a return to principled intervention.
    Robbin-Vergeer BI
    Stanford Law Rev; 1990 Feb; 42(3):745-809. PubMed ID: 10103770
    [No Abstract]   [Full Text] [Related]  

  • 15. Obstetric and Pediatric Provider Perspectives on Mandatory Reporting of Prenatal Substance Use.
    Jarlenski M; Minney S; Hogan C; Chang JC
    J Addict Med; 2019; 13(4):258-263. PubMed ID: 30550393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criminalization of pregnant substance abusers: a health care perspective.
    Popovits RM
    J Health Hosp Law; 1991 Jun; 24(6):169-81. PubMed ID: 10170728
    [No Abstract]   [Full Text] [Related]  

  • 17. Survey of pediatrician practices in retrieving statewide authorized newborn screening results.
    Desposito F; Lloyd-Puryear MA; Tonniges TF; Rhein F; Mann M
    Pediatrics; 2001 Aug; 108(2):E22. PubMed ID: 11483832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal toxicology screening.
    Hansen RL; Evans AT; Gillogley KM; Hughes CS; Krener PG
    J Perinatol; 1992 Sep; 12(3):220-4. PubMed ID: 1432276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive health and blurred professional boundaries.
    Chavkin W; Breitbart V
    Womens Health Issues; 1996; 6(2):89-96. PubMed ID: 8932462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile of apparently healthy neonates with in utero drug exposure.
    Hite C; Shannon M
    J Obstet Gynecol Neonatal Nurs; 1992; 21(4):305-9. PubMed ID: 1379637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.